The VWD example highlights a broader opportunity across hematology: using healthcare data not only to evaluate treatments but also to improve diagnosis, disease management, and patient outcomes
Instead, BPC-157 appears to upgrade minor vessels to assume the functions of blocked major vessels
WATCH | Health Canada warns against unauthorized peptides: The company currently offers peptide therapies and said it will comply with any regulatory changes should they arise to help patients transition care appropriately
Whether your laboratory is focused on metabolic rate markers, organelle-specific activity, or endocrine signaling, Cagrilintide provides a convenient, high-concentration solution for multi-faceted experimental designs
BPC-157 Supports Vascular and Neurological Repair One underappreciated hallmark of long COVID is endothelial dysfunction damage to the lining of blood vessels that impairs circulation, oxygenation, and tissue delivery.7 BPC-157 has demonstrated angiogenic (new blood vessel formation) effects in research models, upregulating VEGFR2 and promoting collateral circulation in ischemic tissue.8 This matters for two reasons: Cardiovascular symptoms (breathlessness, reduced exercise tolerance, tachycardia) may partly reflect impaired tissue oxygenation from vascular damage Neurological symptoms (brain fog, cognitive impairment) may similarly reflect reduced cerebral blood flow BPC-157's neuroprotective effects shown across models of traumatic brain injury, dopamine dysregulation, and serotonin syndrome also suggest value in supporting the neurotransmitter disruption many long COVID patients experience.9 BPC-157 Modulates Inflammation Without Immune Suppression This is critical
